Applied Genetic Technologies Corp. | Key People and Executives
Susan B. Washer
President, Chief Executive Officer & Director
David R. Knop
Executive Director
Tavara K. Andrews
Director
Anne M. VanLent
Independent Director
Ed M. Hurwitz
Independent Director
Jimmy Rosen
Independent Director
Susan B. Washer
President, Chief Executive Officer & Director
William A. Sullivan
Chief Financial Officer
Karen M. Carroll
Vice President-Clinical Development Operations
Lanita C. Scott
VP-Clinical Research & Medical Affairs
Matthew Feinsod
Chief Medical Officer
Mark S. Shearman
Chief Scientific Officer & Vice President
Ivana Magovcevic-Liebisch
Senior Vice President
Rabia Ozden
Vice President-Clinical Research & Development
Stephen W. Potter
Chief Business Officer & Vice President
Jeffrey D. Chulay
Executive Director-Clinical Strategy
David R. Knop
Executive Director
Tavara K. Andrews
Director
Andrew D. Ashe
General Counsel
Anne M. VanLent
Independent Director
Ed M. Hurwitz
Independent Director
James Rosen
Independent Director
| Address |
14193 NW
Alachua Florida 32615
United States
|
|
Employees
|
- |
| Website |
http://www.agtc.com |
| Updated |
07/08/2019 |
| Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. |
